Innovating Works

CRO AVIANO

Desconocido
U-PGx: Ubiquitous Pharmacogenomics U PGx Making actionable pharmacogenomic data and effective treatment... CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO participó en un H2020: H2020-PHC-2014-2015 Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and...
2015-12-09 - 2021-12-31 | Financiado
HERCULES: Comprehensive characterization and effective combinatorial targeting of high grade serous ovarian ca... CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO participó en un H2020: H2020-PHC-2014-2015 The goal of this multidisciplinary project is to comprehensively characterise high-grade serous ovarian cancer (HGS-OvCa) at single-cell lev...
2015-12-02 - 2021-06-30 | Financiado
DiaChemo: Point of care microfluidic device for quantification of chemotherapeutic drugs in small body fluid s... CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO participó en un H2020: H2020-PHC-2014-2015 The decision-making in chemotherapy nowadays depends on standard methods that are liquid chromatography (LC-MS/MS) followed by mass spectrom...
2015-04-13 - 2020-10-31 | Financiado
TRANSPOSON GET NCRNA: Transposon based Forward Genetic Screen for the Identification of ncRNAs involved in Colorectal Canc... CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO tramitó un FP7: In the era of target-based cancer therapies there is still missing a univocal hit for treating cancer metastatic spread, which is ultimately...
Financiado
QUIDPROQUO: Molecular Nanotechnology for Life Science Applications QUantitative Interactomics for Diagnostics... CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO participó en un FP7: The main goal of this proposal is to introduce innovative devices and protocols (based on nano- manipulation, the response of micro-(nano-)m...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.